Statins as potential antimalarial drugs: Low relative potency and lack of synergy with conventional antimalarial drugs

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 5, 2009, Pages 2212-2214

  Wong, Rina P M ^a   Davis, Timothy M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ATORVASTATIN; CHLOROQUINE; DIHYDROARTEMISININ; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN;

ANTIMALARIAL ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SENSITIVITY; HUMAN; HUMAN EXPERIMENT; MALARIA FALCIPARUM; MINIMUM INHIBITORY CONCENTRATION; NORMAL HUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REPEATED DRUG DOSE;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; CULTURE MEDIA; DRUG RESISTANCE; DRUG SYNERGISM; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PYRROLES;

EID: 66149139771     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01469-08     Document Type: Article

References (29)

1. Andersson, M., P. Low, and M. Bakhiet. 1996. Lovastatin inhibits interferon-gamma-induced Trypanosoma brucei brucei proliferation: evidence for mevalonate pathway involvement. J. Interferon Cytokine Res. 16:435-439. (Pubitemid 26195742)
2. Berenbaum, M. C. 1978. A method for testing for synergy with any number of agents. J. Infect. Dis. 137:122-130. (Pubitemid 8289152)
3. Bienvenu, A. L., and S. Picot. 2008. Statins alone are ineffective in cerebral malaria but potentiate artesunate. Antimicrob. Agents Chemother. 52:4203-4204.
4. Borek-Dohalsky, V., J. Huclova, B. Barrett, B. Nemec, I. Ulc, and I. Jelinek. 2006. Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma-pharmacokinetic study. Anal. Bioanal. Chem. 386:275-285. (Pubitemid 44327024)
5. Butcher, G. A., and R. E. Sinden. 2003. Persistence of atovaquone in human sera following treatment: inhibition of Plasmodium falciparum development in vivo and in vitro. Am. J. Trop. Med. Hyg. 68:111-114. (Pubitemid 38234858)
6. Catron, D. M., Y. Lange, J. Borensztajn, M. D. Sylvester, B. D. Jones, and K. Haldar. 2004. Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation. Infect. Immun. 72:1036-1042.
7. Chen, G. Z., L. Foster, and J. L. Bennett. 1990. Antischistosomal action of mevinolin: evidence that 3-hydroxy-methylglutaryl-coenzyme a reductase activity in Schistosoma mansoni is vital for parasite survival. Naunyn Schmiedebergs Arch. Pharmacol. 342:477-482. (Pubitemid 20284133)
8. Cilla, D. D., Jr., L. R. Whitfield, D. M. Gibson, A. J. Sedman, and E. L. Posvar. 1996. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects. Clin. Pharmacol. Ther. 60:687-695. (Pubitemid 27025917)
9. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718. (Pubitemid 10082023)
10. Edstein, M. D., B. M. Kotecka, K. L. Anderson, D. J. Pombo, D. E. Kyle, K. H. Rieckmann, and M. F. Good. 2005. Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration. Antimicrob. Agents Chemother. 49:4421-4422. (Pubitemid 41401005)
11. Fivelman, Q. L., I. S. Adagu, and D. C. Warhurst. 2004. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob. Agents Chemother. 48:4097-4102. (Pubitemid 39434861)
12. Grellier, P., A. Valentin, V. Millerioux, J. Schrevel, and D. Rigomier. 1994. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes. Antimicrob. Agents Chemother. 38: 1144-1148.
13. Jones, P. H., M. H. Davidson, E. A. Stein, H. E. Bays, J. M. McKenney, E. Miller, V. A. Cain, and J. W. Blasetto. 2003. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am. J. Cardiol. 92:152-160. (Pubitemid 36835963)
14. Kobbe, R., N. Schreiber, J. May, and T. Jacobs. 2008. Simvastatin treatment shows no effect on the incidence of cerebral malaria or parasitemia during experimental malaria. Antimicrob. Agents Chemother. 52:1583-1584.
15. Kotecka, B. M., K. H. Rieckmann, T. M. Davis, K. T. Batty, and K. F. Ilett. 2003. Comparison of bioassay and high performance liquid chromatographic assay of artesunate and dihydroartemisinin in plasma. Acta Trop. 87:371-375. (Pubitemid 37272004)
16. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420. (Pubitemid 10222999)
17. Makler, M. T., J. M. Ries, J. A. Williams, J. E. Bancroft, R. C. Piper, B. L. Gibbins, and D. J. Hinrichs. 1993. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am. J. Trop. Med. Hyg. 48:739-741. (Pubitemid 23238452)
18. Montalvetti, A., J. Pena-Diaz, R. Hurtado, L. M. Ruiz-Perez, and D. Gonzalez-Pacanowska. 2000. Characterization and regulation of Leishmania major 3-hydroxy-3-methylglutaryl-CoA reductase. Biochem. J. 349:27-34. (Pubitemid 30440161)
19. Naik, R. S., M. Venkatesan, and D. C. Gowda. 2001. Plasmodium falciparum: the lethal effects of tunicamycin and mevastatin on the parasite are not mediated by the inhibition of N-linked oligosaccharide biosynthesis. Exp. Parasitol. 98:110-114. (Pubitemid 32692300)
20. Nirogi, R. V., V. N. Kandikere, M. Shukla, K. Mudigonda, S. Maurya, R. Boosi, and Y. Anjaneyulu. 2006. Simultaneous quantification of atorvastatin and active metabolites in human plasma by liquid chromatography-tandem mass spectrometry using rosuvastatin as internal standard. Biomed. Chromatogr. 20:924-936. (Pubitemid 44430552)
21. Pradines, B., M. Torrentino-Madamet, A. Fontaine, M. Henry, E. Baret, J. Mosnier, S. Briolant, T. Fusai, and C. Rogier. 2007. Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum. Antimicrob. Agents Chemother. 51:2654-2655.
22. Song, J. L., C. N. Lyons, S. Holleman, B. G. Oliver, and T. C. White. 2003. Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans. Med. Mycol. 41:417-425. (Pubitemid 37441445)
23. Soran, H., and P. Durrington. 2008. Rosuvastatin: efficacy, safety and clinical effectiveness. Expert Opin. Pharmacother. 9:2145-2160.
24. Thavendiranathan, P., A. Bagai, M. A. Brookhart, and N. K. Choudhry. 2006. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 166:2307-2313.
25. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
26. Urbina, J. A., K. Lazardi, E. Marchan, G. Visbal, T. Aguirre, M. M. Piras, R. Piras, R. A. Maldonado, G. Payares, and W. de Souza. 1993. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob. Agents Chemother. 37:580-591.
27. Vial, H. J., J. R. Philippot, and D. F. Wallach. 1984. A reevaluation of the status of cholesterol in erythrocytes infected by Plasmodium knowlesi and P. falciparum. Mol. Biochem. Parasitol. 13:53-65. (Pubitemid 14024946)
28. Wilt, T. J., H. E. Bloomfield, R. MacDonald, D. Nelson, I. Rutks, M. Ho, G. Larsen, A. McCall, S. Pineros, and A. Sales. 2004. Effectiveness of statin therapy in adults with coronary heart disease. Arch. Intern. Med. 164:1427-1436. (Pubitemid 38937854)
29. Wunderlich, F., S. Fiebig, H. Vial, and H. Kleinig. 1991. Distinct lipid compositions of parasite and host cell plasma membranes from Plasmodium chabaudi-infected erythrocytes. Mol. Biochem. Parasitol. 44:271-277.